General Internal Medicine

Obesity Medicine

Questions discussed in this category

In what situations would you recommend metformin in addition to aggressive lifestyle interventions for patients with prediabetes and obesity?

Echouffo-Tcheugui et al., PMID 37039787

1 Answer available

How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?

4 Answers available

How do you counsel someone about metformin use for type 2 diabetes mellitus who is also on a GLP-1 agonist and achieved goal HbA1c, but prefers not to be on metformin anymore?

1 Answer available

Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?

2 Answers available

Should GLP-1 agonists be held during chemotherapy?

3 Answers available

Is there a role for use of GLP1 R agonist or dual agonist therapy for management of post bariatric hypoglycemia and dumping syndrome?

1 Answer available

Papers discussed in this category

BMJ open, 2024 Oct 09

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study.

JAMA network open, 2024 Jul 01

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.

Cureus, 2023 Oct 16

Comparison of the Efficacy of Metformin and Lifestyle Modification for the Primary Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2024 Oct 29

Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.

Related Topics in General Internal Medicine